Download
-+ 0.00%
-+ 0.00%
-+ 0.00%
LeMaitre Vascular Q3 2026 net income falls 13% year over year to $15.02 million; Q3 net sales rise 11% year over year to $67.97 million
Share
Listen to the news
LeMaitre Vascular Q3 2026 net income falls 13% year over year to $15.02 million; Q3 net sales rise 11% year over year to $67.97 million
  • LeMaitre Vascular’s Q3 2026 EPS fell 14% year over year to $0.65.
  • Net sales rose 11% year over year to $67.97 million, while operating expenses climbed 21% to $31.01 million.
  • The company acquired certain B. Braun vascular assets for $19.2 million in October, with customer transitions expected over 18–24 months.
  • Q4 2026 guidance projects EPS of $0.70–$0.75 and net sales of $69.9 million–$71.9 million.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LeMaitre Vascular Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611041605PRIMZONEFULLFEED9870528) on November 04, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending